after 3 vaccines I still get outbreaks on my lower back / suspected vaccination failure; outbreaks on my lower back; extra dose administered; This serious case was reported by a other health professional and described the occurrence of vaccination failure in a 72-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis. The patient’s past medical history included hip replacement (The patient underwent hip replacement surgery 5 years ago.). Concomitant products included valaciclovir (Valacyclovir). On an unknown date, the patient received the 3rd dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: after 3 vaccines I still get outbreaks on my lower back / suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: outbreaks on my lower back) and extra dose administered (Verbatim: extra dose administered). The outcome of the vaccination failure and shingles were not reported and the outcome of the extra dose administered was unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine, Shingles vaccine and Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine. Additional Information: GSK Receipt Date: 14-JAN-2025 The drug dosage for Shingles was reported as 30mg. It was reported that after the patient had a hip replacement 5 years ago and after 3 vaccines, the patient still got outbreaks on her lower back (exhaustion), which led to extra dose administered. The outcome for exhaustion was reported as resolved with sequelae. The symptoms were treated. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding herpes zoster were unknown at the time of reporting.; Sender’s Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, completion of primary vaccination schedule, time to onset of shingles and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingles vaccine (Dose 1, 2 & 3).